Newron Pharmaceuticals SpA (XTER:NP5) Asset Impairment Charge : €0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Newron Pharmaceuticals SpA Asset Impairment Charge?

Newron Pharmaceuticals SpA's Asset Impairment Charge for the six months ended in Jun. 2024 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.

Newron Pharmaceuticals SpA Asset Impairment Charge Historical Data

The historical data trend for Newron Pharmaceuticals SpA's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA Asset Impairment Charge Chart

Newron Pharmaceuticals SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

Newron Pharmaceuticals SpA Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Newron Pharmaceuticals SpA Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Newron Pharmaceuticals SpA Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Newron Pharmaceuticals SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XTER:NP5) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

NWPHF:USA 0QOI:UK NWRN:Switzerland

Address

Via Antonio Meucci 3, Bresso, Milan, ITA, 20091

Website

https://www.newron.com

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.

Executives

Stefan Weber	Board of Directors
Dr. Ulrich Köstlin	Supervisory Board

Newron Pharmaceuticals SpA Headlines

No Headlines